Patrick G. Pilié
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
interferon and immune responses, PARP inhibition in cancer therapy, Prostate Cancer Treatment and Research, Herpesvirus Infections and Treatments, Ubiquitin and proteasome pathways
Most-Cited Works
- → State-of-the-art strategies for targeting the DNA damage response in cancer(2018)1,178 cited
- → PARP Inhibitors: Extending Benefit Beyond BRCA-Mutant Cancers(2019)324 cited
- → Development of PARP and Immune-Checkpoint Inhibitor Combinations(2018)257 cited
- → Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer(2023)179 cited
- → PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma(2020)170 cited
- → ATR Inhibition Induces CDK1–SPOP Signaling and Enhances Anti–PD-L1 Cytotoxicity in Prostate Cancer(2021)139 cited
- → Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma(2020)138 cited
- → Causes of Death Among Patients With Metastatic Prostate Cancer in the US From 2000 to 2016(2021)112 cited
- → Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial(2018)98 cited
- → Targeting ATR in patients with cancer(2024)78 cited